Request a Proposal  

Welcome to Pharm-Olam Insights

Check out our latest white paper! We partnered with Informa Pharma Intelligence to bring you the latest information on COVID-19 and its effect on the clinical landscape.

Understanding-COVID-19_ebook_updated-0723-FINAL-1
The Role of Liquid Biopsies in the Clinical Trial Setting

A liquid biopsy is a testing technique where a sample of blood is analysed for cancer cells from a tumour that is circulating...


(4 minute read)

Tags: Oncology-Hematology Disease

Cancer clinical trials: Recent oncology research studies in review

Oncology is a multi-faceted field of study and a popular one. Cancer clinical trials account for more than 19% of the research...


(4 minute read)

Tags: Oncology-Hematology Disease

Clinical Trials Today: Recent Milestones in Rare Cancer Research

Cancer research has evolved exponentially over the last two centuries. The first time radiation was used to cure cancer...


(3 minute read)

Tags: Rare & Orphan Disease, Oncology-Hematology Disease

Conducting Clinical Trials in Rare Oncology

Rare oncology is a subset of Oncology that encompasses those cancers with the rarest incidence. They may be a common type like...


(3 minute read)

Tags: Rare & Orphan Disease, Oncology-Hematology Disease

Phase I Oncology PD-1 Inhibitor Enrolled 78 Days Early

Pharm-Olam is a mid-sized, global CRO that provides clinical research solutions for rare diseases, oncology, hematology,...


(1 minute read)

Tags: Pharm-Olam Insights, Oncology-Hematology Disease

Effective Cohort Management in Early Phase Oncology Trials

Cohort management is part and parcel of conducting dose-escalation studies, but not all teams effectively manage it....


(5 minute read)

Tags: Pharm-Olam Insights, Oncology-Hematology Disease

Join other Clinical Development experts to receive the latest industry news, trends and insights.

Subscribe to our blog and we'll give you our GDPR Controller & Processor Checklist.

GDPR_Checklist-cover